Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 5/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | P2RY10 | O00398 | 6/20 | 0.35 |
| ▸ | GPR174 | Q9BXC1 | 5/20 | 0.33 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.33 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28786801 | 0.88 | EPHX2 (0.42) | EPHX2CNR1P2RY10GPR174GPR34 | |
| SCHEMBL699087 | 0.86 | EPHX2 (0.37) | EPHX2CNR1P2RY10GPR34 | |
| SCHEMBL9229451 | 0.86 | EPHX2 (0.41) | EPHX2CNR1P2RY10 | |
| SCHEMBL29403911 | 0.86 | EPHX2 (0.41) | EPHX2CNR1P2RY10 | |
| SCHEMBL13030430 | 0.86 | EPHX2 (0.41) | EPHX2CNR1P2RY10 | |
| SCHEMBL78014 | 0.86 | EPHX2 (0.41) | EPHX2CNR1P2RY10 | |
| SCHEMBL1864712 | 0.85 | EPHX2 (0.40) | EPHX2CNR1P2RY10GPR174GPR34 | |
| SCHEMBL22915501 | 0.85 | EPHX2 (0.38) | EPHX2CNR1P2RY10 | |
| SCHEMBL9870753 | 0.82 | CNR1 (0.40) | EPHX2CNR1 | |
| SCHEMBL6295770 | 0.82 | EPHX2 (0.38) | EPHX2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3448926-B1 | CAPS OR CLOSURES MADE FROM A RESIN COMPOSITION COMPRISING POLYETHYLENE | TOTAL RES & TECHNOLOGY FELUY (BE) | 2019-10-09 | — | — | EP | claimed |
| US-20190218379-A1 | Caps or Closures Made From a Resin Composition Comprising Polyethylene | TOTAL RESEARCH & TECHNOLOGY FELUY (BE) | 2019-07-18 | — | — | US | claimed |
| WO-2018037122-A1 | CAPS OR CLOSURES MADE FROM A RESIN COMPOSITION COMPRISING POLYETHYLENE | TOTAL RESEARCH & TECHNOLOGY FELUY (BE) | 2018-03-01 | — | — | WO | claimed |
| WO-2024150714-A1 | PROCESSING STABILIZER, RESIN COMPOSITION, AND ORGANIC MATERIAL STABILIZING METHOD | 住友化学株式会社 | 2024-07-18 | — | — | WO | disclosed |
| US-20240209195-A1 | PROCESS TO PRODUCE AN ADDITIVED COMPOSITION OF POLYETHYLENE COMPRISING POST-CONSUMER RESIN AND CAPS OR CLOSURES MADE FROM THIS COMPOSITION | TOTALENERGIES ONETECH BELGIUM (BE) | 2024-06-27 | — | — | US | disclosed |
| US-20240166672-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-05-23 | — | — | US | disclosed |
| EP-4371988-A1 | PHENOLIC COMPOUND, ORGANIC MATERIAL STABILIZER, RESIN COMPOSITION, AND METHOD FOR STABILIZING ORGANIC MATERIAL | Sumitomo Chemical Company, Limited (JP) | 2024-05-22 | — | — | EP | disclosed |
| WO-2024090435-A1 | PHENOLIC COMPOUND, STABILIZER, ORGANIC MATERIAL COMPOSITION, METHOD FOR STABILIZING ORGANIC MATERIAL, AND METHOD FOR PRODUCING PHENOLIC COMPOUND | 住友化学株式会社 | 2024-05-02 | — | — | WO | disclosed |
| WO-2024075651-A1 | STABILIZER, ORGANIC MATERIAL COMPOSITION, AND ORGANIC MATERIAL STABILIZING METHOD | 住友化学株式会社 | 2024-04-11 | — | — | WO | disclosed |
| EP-4349920-A1 | PHOSPHITE ESTER COMPOSITION | Sumitomo Chemical Company Limited (JP) | 2024-04-10 | — | — | EP | disclosed |
| EP-4323445-A1 | PROCESS TO PRODUCE AN ADDITIVED COMPOSITION OF POLYETHYLENE COMPRISING POST-CONSUMER RESIN AND CAPS OR CLOSURES MADE FROM THIS COMPOSITION | TotalEnergies OneTech Belgium (BE) | 2024-02-21 | — | — | EP | disclosed |
| US-20020032256-A1 | Polybutadiene composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-03-14 | — | — | US | disclosed |
| US-20020002249-A1 | Polymer composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-01-03 | — | — | US | disclosed |
| EP-0823435-B1 | Phosphites, process for producing the same and their use | SUMITOMO CHEMICAL CO (JP) | 2001-11-21 | — | — | EP | disclosed |
| US-20010041761-A1 | Polypropylene resin composition, and molded article and film prepared therefrom | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-11-15 | — | — | US | disclosed |
| US-6242514-B1 | CYCLIC PHOSPHATE OR PHOSPHONATE; HEAT AND OXIDATION STABILIZER ESPECIALLY FOR OLEFIN POLYMERS AND ENGINEERING THERMOPLASTICS | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2001-06-05 | — | — | US | disclosed |
| US-6075159-A | USE AS A STABILIZER FOR AN ORGANIC MATERIAL SUCH AS THERMOPLASTIC RESINS, THERMOSETTING RESINS, NATURAL OR SYNTHETIC RUBBERS, MINERAL OILS, LUBRICATING OILS, ADHESIVES AND PAINTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-06-13 | — | — | US | disclosed |
| US-6046261-A | STABILIZER FOR ORGANIC MATERIAL HAVING EXCELLENT BLOOMING RESISTANCE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-04-04 | — | — | US | disclosed |
| EP-0861847-A2 | Stabilizer composition and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-09-02 | — | — | EP | disclosed |
| EP-0823435-A2 | Phosphites, process for producing the same and their use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-02-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166672-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME | EBPL, ACSL6, ACSL3 | EPHX2 712/4885CNR1 2822/4885P2RY10 65/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.